Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Sonoma Pharmaceuticals - 18 Year Stock Price History | SNOA

Historical daily share price chart and data for Sonoma Pharmaceuticals since 2007 adjusted for splits and dividends. The latest closing stock price for Sonoma Pharmaceuticals as of August 01, 2025 is 2.99.
  • The all-time high Sonoma Pharmaceuticals stock closing price was 69300.00 on July 18, 2007.
  • The Sonoma Pharmaceuticals 52-week high stock price is 6.40, which is 114% above the current share price.
  • The Sonoma Pharmaceuticals 52-week low stock price is 1.75, which is 41.5% below the current share price.
  • The average Sonoma Pharmaceuticals stock price for the last 52 weeks is 3.10.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Sonoma Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 2.9438 2.6800 4.2300 1.8800 2.9900 11.15%
2024 3.6808 3.6400 8.5360 2.5300 2.6900 -25.44%
2023 18.0203 25.4000 40.4000 2.8120 3.6080 -83.89%
2022 57.5572 96.8000 96.8000 20.2000 22.4000 -75.44%
2021 136.8215 146.2000 192.8000 86.4000 91.2000 -37.19%
2020 131.9930 91.0000 196.0000 74.2000 145.2000 66.51%
2019 133.3828 138.2400 194.4000 78.8040 87.2000 -32.01%
2018 507.1895 1045.8000 1045.8000 117.0000 128.2500 -86.93%
2017 1083.4621 925.2000 1425.4200 750.6000 981.0000 8.13%
2016 841.4441 1035.0000 1232.9100 658.8000 907.2000 -12.35%
2015 1011.6064 1260.0000 1647.0000 630.0900 1035.0000 -19.58%
2014 2548.6129 3348.0000 5256.0000 1260.0000 1287.0000 -58.91%
2013 3132.9086 4031.3700 5400.0000 2079.0000 3132.0000 -18.50%
2012 5739.6427 7182.0000 8820.0000 3276.0000 3843.0000 -41.90%
2011 10687.0652 10962.0000 14175.0000 6175.2600 6615.0000 -37.87%
2010 11917.4883 11277.0000 16947.0000 9009.0000 10647.0000 -7.65%
2009 12574.3800 9387.0000 30933.0000 5692.6800 11529.0000 27.97%
2008 19696.8874 26334.0000 43092.0000 2520.0000 9009.0000 -65.12%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.005B $0.014B
Sonoma Pharmaceuticals operates as a pharmaceutical company. It develops and markets solutions for the treatment of dermatological conditions, animal health and advanced tissue care. The company operates primarily in United States, Latin America and Europe. Sonoma Pharmaceuticals formerly known as Oculus Innovative Sciences and is headquatered in Petaluma, California.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $79.248B 30.48
Zoetis (ZTS) United States $64.907B 24.22
Daiichi Sankyo, - (DSNKY) Japan $46.828B 24.00
Takeda Pharmaceutical (TAK) Japan $43.656B 8.91
BeOne Medicines - (ONC) Cayman Islands $33.004B 0.00
Sandoz Group AG (SDZNY) Switzerland $25.084B 0.00
Summit Therapeutics (SMMT) United States $19.584B 0.00
Merck (MKKGY) Germany $16.168B 11.85
Shionogi (SGIOY) Japan $14.172B 14.20
Neurocrine Biosciences (NBIX) United States $12.718B 37.94
United Therapeutics (UTHR) United States $12.391B 10.72
Orion OYJ (ORINY) Finland $11.482B 27.67
IPSEN (IPSEY) France $10.802B 0.00
Stevanato Group S.p.A (STVN) Italy $7.483B 45.76
Grifols, S.A (GRFS) Spain $7.357B 0.00
Corcept Therapeutics (CORT) United States $7.123B 59.44
Ionis Pharmaceuticals (IONS) United States $6.851B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.717B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.853B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.214B 15.86
Soleno Therapeutics (SLNO) United States $4.358B 0.00
Hypermarcas (HYPMY) Brazil $2.987B 19.65
Crinetics Pharmaceuticals (CRNX) United States $2.677B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.602B 9.12
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.451B 13.25
NewAmsterdam Pharma (NAMS) Netherlands $2.449B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.294B 0.00
Ocular Therapeutix (OCUL) United States $1.845B 0.00
Endo (NDOI) United States $1.800B 0.00
ARS Pharmaceuticals (SPRY) United States $1.736B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.703B 0.00
Evotec AG (EVO) Germany $1.413B 0.00
Dyne Therapeutics (DYN) United States $1.401B 0.00
Guardian Pharmacy Services (GRDN) United States $1.323B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.249B 18.13
Harrow (HROW) United States $1.165B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.017B 0.00
Ardelyx (ARDX) United States $1.014B 0.00
Akebia Therapeutics (AKBA) United States $0.968B 0.00
Collegium Pharmaceutical (COLL) United States $0.959B 5.18
Enliven Therapeutics (ELVN) United States $0.923B 0.00
ProKidney (PROK) United States $0.811B 0.00
Xeris Biopharma Holdings (XERS) United States $0.796B 0.00
Cronos Group (CRON) Canada $0.764B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.716B 0.00
KalVista Pharmaceuticals (KALV) United States $0.681B 0.00
Zevra Therapeutics (ZVRA) United States $0.607B 0.00
Relay Therapeutics (RLAY) United States $0.603B 0.00
Xencor (XNCR) United States $0.592B 0.00
Organogenesis (ORGO) United States $0.586B 0.00
Tourmaline Bio (TRML) United States $0.568B 0.00
Theravance Biopharma (TBPH) United States $0.558B 0.00
USANA Health Sciences (USNA) United States $0.547B 11.01
Elite Pharmaceuticals (ELTP) United States $0.546B 0.00
Bioventus (BVS) United States $0.536B 13.58
Oruka Therapeutics (ORKA) United States $0.509B 0.00
Siga Technologies (SIGA) United States $0.472B 9.87
Savara (SVRA) United States $0.448B 0.00
Aquestive Therapeutics (AQST) United States $0.381B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.376B 10.17
AleAnna (ANNA) United States $0.339B 0.00
Nanobiotix S.A (NBTX) France $0.325B 0.00
Altimmune (ALT) United States $0.299B 0.00
Aldeyra Therapeutics (ALDX) United States $0.299B 0.00
Esperion Therapeutics (ESPR) United States $0.281B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.277B 0.00
Nektar Therapeutics (NKTR) United States $0.269B 0.00
Heron Therapeutics (HRTX) United States $0.264B 0.00
Nature's Sunshine Products (NATR) United States $0.259B 16.10
OmniAb (OABI) United States $0.233B 0.00
Galectin Therapeutics (GALT) United States $0.230B 0.00
Larimar Therapeutics (LRMR) United States $0.222B 0.00
4D Molecular Therapeutics (FDMT) United States $0.208B 0.00
MediWound (MDWD) Israel $0.201B 0.00
China SXT Pharmaceuticals (SXTC) China $0.181B 0.00
Lyell Immunopharma (LYEL) United States $0.175B 0.00
Journey Medical (DERM) United States $0.171B 0.00
Profound Medical (PROF) Canada $0.167B 0.00
Aclaris Therapeutics (ACRS) United States $0.166B 0.00
Liminatus Pharma (LIMN) United States $0.163B 0.00
Lexeo Therapeutics (LXEO) United States $0.157B 0.00
Korro Bio (KRRO) United States $0.140B 0.00
Avita Medical (RCEL) United States $0.140B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.124B 0.00
Cardiol Therapeutics (CRDL) Canada $0.123B 0.00
Protara Therapeutics (TARA) United States $0.120B 0.00
Inhibikase Therapeutics (IKT) United States $0.117B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.113B 0.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
Achieve Life Sciences (ACHV) Canada $0.091B 0.00
Fractyl Health (GUTS) United States $0.090B 0.00
Champions Oncology (CSBR) United States $0.087B 19.75
Metagenomi (MGX) United States $0.086B 0.00
Surrozen (SRZN) United States $0.086B 0.00
Avalo Therapeutics (AVTX) United States $0.085B 0.00
VAXART, INC (VXRT) United States $0.085B 0.00
ESSA Pharma (EPIX) Canada $0.083B 0.00
Arch Biopartners (ACHFF) Canada $0.081B 0.00
Nutriband (NTRB) United States $0.080B 0.00
Vivani Medical (VANI) United States $0.079B 0.00
PMV Pharmaceuticals (PMVP) United States $0.074B 0.00
Pyxis Oncology (PYXS) United States $0.069B 0.00
Inotiv (NOTV) United States $0.069B 0.00
Assertio Holdings (ASRT) United States $0.069B 0.00
Dominari Holdings (DOMH) United States $0.067B 0.00
Wellgistics Health (WGRX) United States $0.066B 0.00
Context Therapeutics (CNTX) United States $0.065B 0.00
Rafael Holdings (RFL) United States $0.059B 0.00
DURECT (DRRX) United States $0.058B 0.00
Telomir Pharmaceuticals (TELO) United States $0.056B 0.00
Unicycive Therapeutics (UNCY) United States $0.055B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.052B 0.00
ElectroCore (ECOR) United States $0.052B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.052B 38.33
Century Therapeutics (IPSC) United States $0.047B 0.00
NRx Pharmaceuticals (NRXP) United States $0.047B 0.00
Jupiter Neurosciences (JUNS) United States $0.046B 0.00
Klotho Neurosciences (KLTO) United States $0.044B 0.00
Prelude Therapeutics (PRLD) United States $0.044B 0.00
Gain Therapeutics (GANX) United States $0.044B 0.00
Acrivon Therapeutics (ACRV) United States $0.040B 0.00
Mural Oncology (MURA) Ireland $0.039B 0.00
Enlivex Therapeutics (ENLV) Israel $0.035B 0.00
PolyPid (PYPD) Israel $0.034B 0.00
Karyopharm Therapeutics (KPTI) United States $0.033B 0.00
Iterum Therapeutics (ITRM) Ireland $0.031B 0.00
Plus Therapeutics (PSTV) United States $0.029B 0.00
FibroGen (FGEN) United States $0.028B 0.00
SCYNEXIS (SCYX) United States $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.027B 0.00
Cosmos Health (COSM) United States $0.027B 0.00
Vivos Therapeutics (VVOS) United States $0.026B 0.00
Scienture Holdings (SCNX) United States $0.025B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.022B 0.00
Natural Alternatives (NAII) United States $0.022B 0.00
Relmada Therapeutics (RLMD) United States $0.021B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Incannex Healthcare (IXHL) Australia $0.017B 0.00
BioLineRx (BLRX) Israel $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Citius Pharmaceuticals (CTXR) United States $0.015B 0.00
Carisma Therapeutics (CARM) United States $0.013B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.013B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
BioVie (BIVI) United States $0.011B 0.00
Ainos (AIMD) United States $0.011B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
Lyra Therapeutics (LYRA) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Aptorum Group (APM) United Kingdom $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
VYNE Therapeutics (VYNE) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Qualigen Therapeutics (QLGN) United States $0.004B 0.00
SHINECO (SISI) China $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 11.35
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 2.28
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00